Klivira
Request demo

Streamlining Enhertu Prior Authorization with Klivira

Klivira automates the complex Enhertu prior authorization process, accelerating patient access to critical oncology treatments and reducing administrative burden.

Managing prior authorizations for high-cost oncology drugs like Enhertu presents significant administrative burden for revenue cycle teams. The volume and specificity of payer requirements often lead to delays, impacting patient care and increasing operational costs. Klivira provides a robust solution to these challenges, ensuring efficient processing of Enhertu prior authorization requests.

The Complexity of Enhertu Prior Authorization

Enhertu, a targeted therapy for specific HER2-positive cancers, often requires meticulous documentation and adherence to stringent payer-specific medical policies. The high volume of requests across commercial, Medicare Advantage, and Medicaid managed care plans, coupled with evolving clinical criteria, makes manual processing a significant bottleneck for oncology practices and health systems.

Common Challenges in Enhertu PA Management

  • Varied and frequently updated payer-specific medical policies and clinical criteria.
  • Significant administrative time spent on manual data entry and form completion.
  • Delays in treatment initiation due to extended prior authorization turnaround times.
  • High denial rates stemming from incomplete documentation or non-adherence to guidelines.
  • Resource drain from managing appeals and resubmissions for denied Enhertu PAs.
  • Lack of real-time visibility into authorization status across multiple payer portals.

Klivira's Automated Solution for Enhertu PA

Klivira leverages intelligent automation to streamline the entire Enhertu prior authorization workflow. Our platform integrates directly with your EMR to extract necessary clinical data, auto-populates payer-specific forms, and intelligently navigates payer portals. This end-to-end automation minimizes manual effort, reduces errors, and accelerates the submission process for high-volume oncology medications.

Seamless EMR Integration and Data Exchange

Our platform is built for interoperability, utilizing standards such as SMART on FHIR for secure, efficient data exchange with leading EMR systems. Klivira supports both traditional X12 278 electronic prior authorization transactions and advanced ePA workflows, including those aligned with the Da Vinci PAS implementation guide. This ensures that all relevant patient and clinical data required for Enhertu prior authorization is accurately and securely transmitted.

Operational Impact and Enhanced Patient Access

By automating Enhertu prior authorization, Klivira significantly reduces the administrative burden on your staff, allowing them to focus on patient care. Our solution contributes to lower denial rates, faster treatment initiation, and improved patient satisfaction. This operational efficiency translates into substantial cost savings and optimized revenue cycle performance for your organization.

Frequently asked questions

How does Klivira integrate with our EMR for Enhertu prior authorization?

Klivira integrates seamlessly with major EMR systems using secure, standards-based protocols like SMART on FHIR. This allows our platform to automatically extract relevant patient demographics, clinical notes, lab results, and medication history directly from the EMR, populating the necessary fields for Enhertu prior authorization requests without manual input.

What payer types does Klivira support for Enhertu prior authorization?

Klivira supports a comprehensive range of payer types for Enhertu prior authorization, including commercial health plans, Medicare Advantage plans, and state-specific Medicaid managed care organizations. Our system is continuously updated to reflect the latest payer-specific requirements and submission channels, whether via X12 278, proprietary portals, or other ePA methods.

How does Klivira handle Enhertu prior authorization denials?

Klivira's platform provides tools to proactively identify potential denial risks before submission. In the event of an Enhertu prior authorization denial, our system facilitates efficient appeals management by organizing relevant clinical documentation and streamlining the resubmission process, helping to overturn denials and expedite patient access to treatment.

Is Klivira compliant with HIPAA for Enhertu PA data?

Yes, Klivira is built with robust security measures and strict adherence to HIPAA regulations. We prioritize the protection of all ePHI involved in the prior authorization process, employing advanced encryption, access controls, and audit trails to ensure data integrity and confidentiality for all Enhertu-related information.

What specific data is required for Klivira to process an Enhertu prior authorization?

For Enhertu prior authorization, Klivira typically requires patient demographics, diagnosis codes (ICD-10), medication details (NDC, dosage, frequency), relevant clinical notes supporting medical necessity, previous treatment history, and laboratory results (e.g., HER2 status). Our system guides users to ensure all payer-specific data elements are captured.

Related coverage

Streamlining prior authorization by payer

Streamlining prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo